<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Transient <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> often results in secondary ischemic/reperfusion injury, the pathogenesis of which remains unclear </plain></SENT>
<SENT sid="1" pm="."><plain>This study provides a comprehensive, temporal description of the molecular events contributing to neuronal injury after transient <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Intraluminal middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) was performed to induce a 2-h <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> with reperfusion </plain></SENT>
<SENT sid="3" pm="."><plain>Microarray analysis was then performed on the <z:mpath ids='MPATH_124'>infarct</z:mpath> cortex of <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase-1 (a major <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzyme) knockout (Gpx1(-/-)) mice at 8 and 24h postreperfusion to identify differential gene expression profile patterns and potential alternative injury cascades in the absence of Gpx1, a crucial <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzyme, in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Genes with at least Â±1.5-fold change in expression at either time point were considered significant </plain></SENT>
<SENT sid="5" pm="."><plain>Global transcriptomic analyses demonstrated that 70% of the WT-MCAO profile overlapped with that of Gpx1(-/-)-MCAO, and 28% vice versa </plain></SENT>
<SENT sid="6" pm="."><plain>Critical analysis of the 1034 gene probes specific to the Gpx1(-/-)-MCAO profile revealed regulation of additional novel pathways, including the p53-mediated proapoptotic pathway and Fas ligand (CD95/Apo1)-mediated pathways; downplay of the Nrf2 antioxidative cascade; and ubiquitin-proteasome system dysfunction </plain></SENT>
<SENT sid="7" pm="."><plain>Therefore, this comparative study forms the foundation for the establishment of screening platforms for target definition in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> intervention </plain></SENT>
</text></document>